Duchenne muscular dystrophy (DMD) - associated cardiomyopathy research hub

Repurposing empagliflozin for Duchenne muscular dystrophy-associated cardiomyopathy in children 6-18 years of age

This study looks at whether a medicine called empagliflozin can help children and young people (aged 6-18) with Duchenne muscular dystrophy (DMD) who also have heart problems. It aims to find the right dose and check if it's safe and helpful.